相关实验视频
Updated: Jul 7, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
欧巴林通过提升microRNA-211-5p和抑制JAK2/STAT3通路来改善绝经后的骨质疏松症
1Department of Orthopedics, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China.
欧巴提林是一种来自亚洲 (Artemisia asiatica Nakai) 的化合物,显示出治疗绝经后骨质疏松症 (PMOP) 的前景. 它通过增加miR-211-5p水平和抑制JAK2 / STAT3通路而起作用,改善PMOP大鼠的骨健康.
科学领域:
- 药理学和传统医学的医学.
- 分子生物学分子生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 绝经后骨质疏松症 (PMOP) 是一个重要的全球性妇女健康问题.
- 微RNAs (miRNAs) 在骨质疏松症的发展中起着至关重要的作用.
- 欧巴提林 (Eupatilin) 是来自亚洲 (Artemisia asiatica Nakai) 的一种药物,它在各种疾病中表现出抑制作用.
研究的目的:
- 调查欧巴林在绝经后骨质疏松症中的作用和潜在机制.
- 探索Eupatilin,miR-211-5p和PMOP中的JAK2/STAT3通路之间的关系.
主要方法:
- 通过卵巢切除建立了一个PMOP大鼠模型,并用Eupatilin,miR-211-5p或JAK2干扰剂进行治疗.
- 评估骨矿物质密度,生物力学参数,血清标志物 (性酸酶,,) 和组织学变化.
- 在MC3T3-E1细胞中利用了细胞活力,细胞毒性和矿化试验;分析了miRNA-mRNA相互作用.
主要成果:
- 欧巴林治疗通过促进骨质细胞增殖和矿化,改善了PMOP大鼠的病态状况.
- PMOP大鼠表现出下调的miR-211-5p和上调的JAK2/STAT3通路.
- 通过对miR-211-5p和eupatilin进行上调,通过抑制JAK2/STAT3通路,进一步改善PMOP状况;JAK2抵消了miR-211-5p的影响.
结论:
- 欧巴林通过调节miR-211-5p并抑制JAK2/STAT3通路来减轻绝经后的骨质疏松症.
- 这项研究表明Eupatilin是PMOP治疗的潜在治疗剂.
- 这些发现突显了PMOP中针对miR-211-5p/JAK2/STAT3轴的治疗潜力.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
相关概念视频
Drugs that Stabilize Microtubules
The JAK-STAT Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...